Radiotherapy-induced hyperthyroidism in a cystinotic kidney transplant patient with Hodgkin lymphoma

Pediatric Transplantation

Volumn 15, Issue 3, 2011, Pages

  Guzzo, Isabella ^a   Di Zazzo, Giacomo ^a   Grossi, Armando ^a   Greco, Marcella ^a   Dello Strologo, Luca ^a  

^a BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

Author keywords

cystinosis; hyperthyroidism; post transplant lymphoproliferative disorders; radiotherapy

Indexed keywords

AZATHIOPRINE; BLEOMYCIN; CREATININE; CYCLOSPORIN; DACARBAZINE; DOXORUBICIN; HLA A1 ANTIGEN; HLA B44 ANTIGEN; HLA DR1 ANTIGEN; HLA DR4 ANTIGEN; LYMPHOCYTE ANTIBODY; MERCAPTAMINE; STEROID; TACROLIMUS; TECHNETIUM 99M; THYROGLOBULIN ANTIBODY; THYROID HORMONE; THYROID PEROXIDASE ANTIBODY; THYROTROPIN; VINBLASTINE;

ACUTE KIDNEY FAILURE; ADULT; ARTICLE; BODY WEIGHT; CADAVER DONOR; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER REGRESSION; CANCER STAGING; CASE REPORT; CHEMOSIS; CREATININE BLOOD LEVEL; CYSTINOSIS; DIARRHEA; DISEASE COURSE; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG SUBSTITUTION; DRUG WITHDRAWAL; EPSTEIN BARR VIRUS INFECTION; EXOPHTHALMOS; FANCONI RENOTUBULAR SYNDROME; FEVER; GLOMERULUS FILTRATION RATE; GROWTH RETARDATION; HAPLOTYPE; HODGKIN DISEASE; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERTHYROIDISM; HYPOTHYROIDISM; IMMUNOSUPPRESSIVE TREATMENT; INSOMNIA; KIDNEY FUNCTION; KIDNEY TRANSPLANTATION; LEUKOCYTE COUNT; LOW DRUG DOSE; MALE; MULTIPLE CYCLE TREATMENT; OLIGOSPERMIA; PHOTOPHOBIA; SYSTOLIC HYPERTENSION; TACHYCARDIA; THYROID SCINTISCANNING; THYROIDECTOMY; TREATMENT OUTCOME; ULTRASOUND; WEIGHT REDUCTION;

ADULT; FANCONI SYNDROME; HODGKIN DISEASE; HUMANS; HYPERTHYROIDISM; KIDNEY DISEASES; KIDNEY TRANSPLANTATION; MALE; MUTATION; RADIATION ONCOLOGY; RADIOTHERAPY; THYROID GLAND; THYROID HORMONES; TREATMENT OUTCOME;

EID: 78449286283     PISSN: 13973142     EISSN: 13993046     Source Type: Journal    
DOI: 10.1111/j.1399-3046.2009.01274.x     Document Type: Article

References (23)

1. Burke JR, El-Bishti MM, Maisey MN, Chantler C,. Hypothyroidism in children with cystinosis. Arch Dis Child 1978: 53: 947-951. (Pubitemid 9051172)
2. Chan AM, Lynch MJG, Bailey JD, Ezrim C, Frazer D,. Hypothyroidism in cystinosis. Am J Med 1970: 48: 678-692.
3. Lucky AW, Howley PM, Megyesi K, Spielberg SP, Schulman JD,. Endocrine studies in cystinosis: Compensated primary hypothyroidism. J Pediatr 1977: 91: 204-210. (Pubitemid 8152107)
4. Bercu BB, Orloff S, Schulman JD,. Pituitary resistance to thyroid hormone in cystinosis. J Clin Endocrinol Metab 1980: 51: 1262-1268. (Pubitemid 11199610)
5. Almond PS, Matas AJ, Nakhleh RE, et al., Renal transplantation for infantile cystinosis: Long-term follow-up. J Pediatr Surg 1993: 28: 232-238. (Pubitemid 23064352)
6. Broyer M, Tete MJ, Gubler MC,. Late symptoms in infantile cystinosis. Pediatr Nephrol 1987: 1: 519-524. (Pubitemid 18016654)
7. Gahl WA, Balog JZ, Kleta R,. Nephropathic cystinosis in adults: Natural history and effects of oral cysteamine therapy. Ann Intern Med 2007: 147: 242-250. (Pubitemid 351664580)
8. Geelen JM, Monnens LA, Levtchenko EN,. Follow-up and treatment of adults with cystinosis in the Netherlands. Nephrol Dial Transplant 2002: 17: 1766-1770. (Pubitemid 35174287)
9. Shroff R, Rees L,. The post-transplant lymphoproliferative disorders-a literature review. Pediatr Nephrol 2004: 19: 369-377. (Pubitemid 38477398)
10. Caillard S, Agodoa LY, Bohen EM, Abbott KC,. Myeloma, Hodgkin disease, and lymphoid leukaemia after renal transplantation: Characteristics, risk factors and prognosis. Transplantation 2006: 81: 888-895.
11. Caillard S, Lelong C, Pessione F, Moulin B,. Post-transplant lymphoproliferative disorders occurring after renal transplantation in adults: Report of 230 cases from the French Registry. Am J Transplant 2006: 6: 2735-2742. (Pubitemid 44571695)
12. Pascual J,. Post-transplant lymphoproliferative disorder-the potential of proliferation signal inhibitors. Nephrol Dial Transplant 2007: 22 (Suppl. 1): 27-35.
13. Von Der Weid NX,. Adult life after surviving lymphoma in childhood. Support Care Cancer 2008: 16: 339-345.
14. Sklar C, Whitton J, Mertens A, et al., Abnormalities of the thyroid in survivors of Hodgkin's disease: Data from the childhood cancer survivor study. J Clin Endocrinol Metab 2000: 85: 3227-3232.
15. Bethge W, Guggenberger D, Bamberg M, Kanz L, Bokemeyer C,. Thyroid toxicity of treatment for Hodgkin's disease. Ann Hematol 2000: 79: 114-118. (Pubitemid 30195607)
16. Jereczek-Fossa BA, Alterio D, Jassem J, Gibelli B, Tradati N, Orecchia R,. Radiotherapy-induced thyroid dysfunction. Cancer Treat Rev 2004: 30: 369-384.
17. Mortimer RH, Hill GE, Galligan JP, Bransden AI, Tyack SA, Roeser HP,. Hypothyroidism and Graves' disease after mantle irradiation: A follow up study. Aust N Z J Med 1986: 16: 347-351. (Pubitemid 17195234)
18. Hancock SL, Cox RS, McDougall IR,. Thyroid diseases after treatment of Hodgkin's disease. N Engl J Med 1991: 325: 599-605.
19. Badenhoop K, Schwartz G, Walfish PG, Drummond V, Usadel KH, Bottazzo GF,. Susceptibility to thyroid autoimmune disease: Molecular analysis of HLA-D region genes identifies new markers for goitrous Hashimoto's thyroiditis. J Clin Endocrinol Metab 1990: 71: 1131-1137.
20. Jacobson E, Huber A, Tomer Y,. The HLA gene complex in thyroid autoimmunity: From epidemiology to aetiology. J Autoimmun 2008: 30: 58-62.
21. Petrone A, Giorgi G, Mesturino CA, et al., Association of DRB1*04-DQB1*0301 haplotype and lack of association of two polymorphic sites at CTLA-4 gene with Hashimoto's thyroiditis in an Italian population. Thyroid 2001: 11: 171-175. (Pubitemid 32221042)
22. Peterson M, Keeling CA, McDougall IR,. Hyperthyroidism with low radioiodine uptake after head and neck irradiation for Hodgkin's disease. J Nucl Med 1989: 30: 255-257. (Pubitemid 19048523)
23. Madanat LM, Lahteenmaki PM, Alin J, Salmi TT,. The natural history of thyroid function abnormalities after treatment for childhood cancer. Eur J Cancer 2007: 43: 1161-1170. (Pubitemid 46590737)